BRPI0414382A - processo para preparação de 4-(4-aminofenil)-3-morfolinona - Google Patents

processo para preparação de 4-(4-aminofenil)-3-morfolinona

Info

Publication number
BRPI0414382A
BRPI0414382A BRPI0414382-5A BRPI0414382A BRPI0414382A BR PI0414382 A BRPI0414382 A BR PI0414382A BR PI0414382 A BRPI0414382 A BR PI0414382A BR PI0414382 A BRPI0414382 A BR PI0414382A
Authority
BR
Brazil
Prior art keywords
morpholinone
aminophenyl
preparation
preparing
nitrophenyl
Prior art date
Application number
BRPI0414382-5A
Other languages
English (en)
Inventor
Christian Thomas
Mathias Berwe
Alexander Straub
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BRPI0414382A publication Critical patent/BRPI0414382A/pt
Publication of BRPI0414382B1 publication Critical patent/BRPI0414382B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE 4-(4-AMINOFENIL)-3-MORFOLINONA". A presente invenção refere-se a um processo para preparação de 4-(4-aminofenil)-3-morfolinona pela reação de 4-(4-nitrofenil)-3-morfolinona com hidrogênio em presença de um catalisador de hidrogenação, caracterizado pelo fato de que a reação ocorre em um álcool alifático.
BRPI0414382-5A 2003-09-15 2004-09-09 Processo para preparação de 4-(4-aminofenil)-3-morfolinona BRPI0414382B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10342570A DE10342570A1 (de) 2003-09-15 2003-09-15 Verfahren zur Herstellung von 4-(4-Aminophenyl)-3-morpholinon
DE10342570.5 2003-09-15
PCT/EP2004/010054 WO2005026135A1 (de) 2003-09-15 2004-09-09 Verfahren zur herstellung von 4-(4-aminophenyl)-3-morpholinon

Publications (2)

Publication Number Publication Date
BRPI0414382A true BRPI0414382A (pt) 2006-11-21
BRPI0414382B1 BRPI0414382B1 (pt) 2014-01-28

Family

ID=34305779

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414382-5A BRPI0414382B1 (pt) 2003-09-15 2004-09-09 Processo para preparação de 4-(4-aminofenil)-3-morfolinona

Country Status (22)

Country Link
US (1) US7598378B2 (pt)
EP (1) EP1664004B1 (pt)
JP (1) JP4852419B2 (pt)
KR (1) KR101148264B1 (pt)
CN (1) CN100430384C (pt)
AU (1) AU2004272255B2 (pt)
BR (1) BRPI0414382B1 (pt)
CA (1) CA2538906C (pt)
CY (1) CY1116644T1 (pt)
DE (1) DE10342570A1 (pt)
DK (1) DK1664004T3 (pt)
EG (1) EG26605A (pt)
ES (1) ES2545072T3 (pt)
HU (1) HUE025273T2 (pt)
IL (1) IL174194A (pt)
IN (1) IN2012DN00411A (pt)
MX (1) MXPA06002883A (pt)
PL (1) PL1664004T3 (pt)
PT (1) PT1664004E (pt)
SI (1) SI1664004T1 (pt)
WO (1) WO2005026135A1 (pt)
ZA (1) ZA200602093B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100898361B1 (ko) 2008-07-03 2009-05-20 주식회사 레고켐 바이오사이언스 Ｐ4 위치에 사이클릭 아미독심 또는 사이클릭 아미드라존기를 가지는 ＦＸａ 저해제, 이의 유도체, 제조방법 및이를 함유하는 의약 조성물
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
US20120283434A1 (en) 2010-01-04 2012-11-08 Enantia, S.L. Process for the preparation of rivaroxaban and intermediates thereof
DE102010018299A1 (de) * 2010-04-23 2011-10-27 Archimica Gmbh Verfahren zur Herstellung von 4-(4-Aminophenyl)-morpholin-3-on
AU2011300365A1 (en) * 2010-09-07 2013-05-02 Symed Labs Limited Processes for the preparation of 4-{4-[5(S)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl} morpholin-3-one
EP2630143B1 (en) 2010-10-18 2017-11-29 Apotex Pharmachem Inc. Processes for the preparation of rivaroxaban and intermediates thereof
WO2012140061A1 (en) 2011-04-11 2012-10-18 Sandoz Ag Method for the preparation of substituted oxazolidinones
GEP20156397B (en) 2011-05-06 2015-11-10 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Process for the preparation of a rivaroxaban and intermediates formed in said process
WO2012156983A1 (en) * 2011-05-16 2012-11-22 Symed Labs Limited Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
CN102320988B (zh) * 2011-06-03 2014-04-09 中国科学院上海有机化学研究所 4-(4-氨基苯基)-3-吗啉酮中间体酰胺、合成方法和用途
CN103288814B (zh) * 2012-02-24 2016-07-06 国药集团国瑞药业有限公司 一种利伐沙班中间体的制备方法
CN102746288B (zh) * 2012-07-24 2015-04-08 常州制药厂有限公司 一种抗凝血药及其关键中间体的制备方法
IN2013MU01113A (pt) 2013-03-25 2015-06-19 Glenmark Generics Ltd
KR20140127651A (ko) * 2013-04-25 2014-11-04 주식회사 종근당 4-(4-아미노페닐)-3-모폴리논의 신규한 제조 방법
CN103232446B (zh) * 2013-05-17 2015-09-23 天津药物研究院 一种噁唑烷酮衍生物晶型ⅱ及其制备方法和用途
CN105980381A (zh) 2013-11-08 2016-09-28 拜耳医药股份有限公司 取代的尿嘧啶及其用途
CN103709116B (zh) * 2013-12-10 2015-09-23 四川大学 一种4-(4-烷氧羰氨基)苯基-3-吗啉酮的制备方法
CN103755657B (zh) * 2013-12-25 2015-10-14 湖南方盛制药股份有限公司 一种利伐沙班中间体的制备方法
CN104974059B (zh) * 2014-04-14 2016-11-16 北大方正集团有限公司 一种利伐沙班中间体及其制备方法
CN105085370B (zh) * 2014-04-22 2017-04-12 北大方正集团有限公司 (s)‑1‑卤代‑2‑[2‑(1,3‑二氧异吲哚)基]乙基氯甲酸酯及其制备方法
WO2016030669A1 (en) 2014-08-25 2016-03-03 Cipla Limited Process for the preparation of rivaroxaban
CN104478820B (zh) * 2014-12-22 2016-08-31 杭州瀚康生物医药科技有限公司 一种利伐沙班中间体的制备方法
CN104817548B (zh) * 2015-03-19 2017-12-01 郑州轻工业学院 一种对氢氧化锂、氢氧化钠、氢氧化钾可视化选择性识别的有机小分子
HU231119B1 (hu) 2018-01-12 2020-11-30 Richter Gedeon Nyrt. Eljárás 4-(4-aminofenil)morfolin-3-on előállítására
CN109651287A (zh) * 2019-01-18 2019-04-19 吕东 一种4-(4-氨基苯基)吗啉酮的制备方法
US12168167B2 (en) * 2023-01-11 2024-12-17 Kenneth W. Rittmann Golf club head cover device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279880A (en) 1965-07-12 1966-10-18 Eastman Kodak Co Polyester textile material dyed with 1-hydroxy-4-n-p-(2'-pyrrolidonyl-1-) phenyl-amino anthraquinones
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
CA2195107A1 (en) * 1994-08-02 1996-02-15 Richard Alexander Jelley Azetidine, pyrrolidine and piperidine derivatives
WO1998000134A1 (en) * 1996-06-28 1998-01-08 Merck & Co., Inc. Fibrinogen receptor antagonists
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
EP1479676A1 (en) 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Benzimidazole-derivatives as factor xa inhibitors
EP1479675A1 (en) 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Indazole-derivatives as factor Xa inhibitors

Also Published As

Publication number Publication date
ZA200602093B (en) 2007-05-30
JP2007505821A (ja) 2007-03-15
BRPI0414382B1 (pt) 2014-01-28
CN1852902A (zh) 2006-10-25
CY1116644T1 (el) 2017-03-15
US7598378B2 (en) 2009-10-06
DK1664004T3 (en) 2015-09-07
AU2004272255A1 (en) 2005-03-24
PL1664004T3 (pl) 2015-11-30
CN100430384C (zh) 2008-11-05
HK1098134A1 (zh) 2007-07-13
IL174194A0 (en) 2006-08-01
US20070066611A1 (en) 2007-03-22
CA2538906A1 (en) 2005-03-24
ES2545072T3 (es) 2015-09-08
IL174194A (en) 2010-11-30
EP1664004B1 (de) 2015-06-24
EG26605A (en) 2014-03-23
EP1664004A1 (de) 2006-06-07
SI1664004T1 (sl) 2015-10-30
IN2012DN00411A (pt) 2015-08-21
PT1664004E (pt) 2015-09-21
KR101148264B1 (ko) 2012-05-21
WO2005026135A1 (de) 2005-03-24
KR20060070561A (ko) 2006-06-23
AU2004272255B2 (en) 2011-01-06
JP4852419B2 (ja) 2012-01-11
HUE025273T2 (en) 2016-02-29
MXPA06002883A (es) 2006-06-05
DE10342570A1 (de) 2005-04-14
CA2538906C (en) 2013-04-23

Similar Documents

Publication Publication Date Title
BRPI0414382A (pt) processo para preparação de 4-(4-aminofenil)-3-morfolinona
ES2549864T3 (es) Producción de dihidronepetalactona por hidrogenación de nepetalactona
BR0317023A (pt) Processo para produção de álcool
BRPI0714558B8 (pt) processo para a preparação de (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil)-fenol
BRPI0406427B8 (pt) processo para a preparação de roflumilast
BRPI0514558A (pt) processo para a preparação de ácido fórmico por decomposição térmica de formiatos de amÈnio de aminas terciárias
BRPI0507129A (pt) processo para a preparação de 3-pentenonitrila pela hidrocianação de 1,3-butadieno
BRPI0415200A (pt) processo para a fabricação de metilmercaptano
BRPI0719264B8 (pt) processo para a preparação de nebivolol
BRPI0801178A2 (pt) processo para a moldagem por prensagem e tÊmpera de uma peÇa bruta de aÇo em uma prensa de estampar
BRPI0515898A (pt) processos para preparar alquil eter aminas/alquilaminas alcoxiladas com distribuição máxima, suas composições, tensoativos e formulações herbicidas estáveis
BR0214238A (pt) Processo para a preparação de bis (sililorgano) aminas
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BRPI0411209A (pt) uso de derivados isoindolinona como inseticidas
PY0532063A (es) Generación de plantas con contenido alterado de aceite"
BRPI0816830A8 (pt) Processo para a preparação de derivados de 2,2-diflúor-etilamina por hidrogenação de amida
BRPI0517390A (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepina
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BRPI0503815A (pt) processo para produção de mercaptoorganil (alcoxissilano)
BR0214956A (pt) Processo para a preparação de derivados da [1,4,5]-oxadiazepina
ATE307598T1 (de) Verwendung eines zyklischen ethers zur herstellung von mitteln, die die glukosetoleranz beeinflussen
BR0003852A (pt) Pomada nasal a base de petrolato
BRPI0401037A (pt) Processo para a preparação de n-metil-dialquilaminas a partir de dialquilaminas secundárias e formaldeìdo
BRPI0514808A (pt) processo para a telomerização de olefinas não cìclicas
BRPI0411717A (pt) processo para a preparação de acilsulfamoibenzamidas

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER SHERING PHARMA AKTIENGESELLSCHAFT (DE)

Free format text: TRANFERIDO POR FUSAO DE: BAYER HEALTHCARE AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/09/2004, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B25A Requested transfer of rights approved
B25G Requested change of headquarter approved
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 09/09/2024